Micronized Progesterone: A New Option for Women's Health Care

Article Abstract:

Progesterone is a fundamental female hormone, discovered in 1934, with numerous potential treatment uses. Pure progesterone is rendered ineffective by the gastrointestinal system if taken orally, so synthetic compounds were developed, which are effective but cause adverse side effects such as depression and weight gain. The Food and Drug Administration, in May 1998, approved micronized progesterone for use in treating secondary amenorrhea.

Health aspects, Laws, regulations and rules, United States. Food and Drug Administration, Progesterone, Amenorrhea

---

Managing Allergic Rhinitis

Article Abstract:

Diagnosing allergic rhinitis (AR) involves taking the patient's history and thoroughly examining the patient's mouth, nose and ears. Skin or blood tests to diagnose AR are unreliable because of the high incidence of false-positive and false-negative results. AR afflicts almost 20% of Americans and accounts for 1 out of every 11 visits to health care providers.

Care and treatment, Hay-fever, Hay fever

---

Similar abstracts:

• Abstracts: Mechanism of HIV persistence: implications for vaccines and therapy. part 2 An immunovirological study of central nervous system involvement during HIV-1 infection of chimpanzees
• Abstracts: Nations for Mental Health. Cities at risk
• Abstracts: Keeping children and families in the center of our concern: Ambulatory Pediatric Association presidential address
• Abstracts: Modest ambition. Powers of judgement. Westminster, here we come: against the odds
• Abstracts: Academic physicians' participation in organized medicine. For our patients, not for profits: a call for action

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.